Search Results 171-180 of 3083 for Mão Morta de Volkmann
PRM-151 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is ...
Mayo Clinic's Wilfried O. Rossoll, Ph.D., studies molecular pathomechanisms of abnormal protein aggregation in neurodegenerative diseases.
Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or ...
About this study. The purpose of this study is to record the visual analog pain score (VAS) score given to the surgical team by the patient and compare this ...
Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...
Research faculty in the Division of Gastroenterology and Hepatology at Mayo Clinic's campuses are pictured.
SUMMARY. The primary research interest of Marin Veldic, M.D., is in molecular epigenetics and development of novel treatment protocols for bipolar disorder.
About this study. The primary objective of this registry is to obtain long-term survivorship data for the use of fresh OCAs in cartilage repair and ...
Damian Di Florio, Ph.D. student in the Clinical and Translational Science track at Mayo Clinic, shares research on sex differences in deadly heart disease.
Earl Nolting was diagnosed with Waldenström Macroglobulinemia (WM) in 2000. WM is a rare disorder involving enlargement of the liver and spleen associated ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.